| Literature DB >> 25082194 |
Sandra S McAllister1, Robert A Weinberg2.
Abstract
Recent pre-clinical and clinical research has provided evidence that cancer progression is driven not only by a tumour's underlying genetic alterations and paracrine interactions within the tumour microenvironment, but also by complex systemic processes. We review these emerging paradigms of cancer pathophysiology and discuss how a clearer understanding of systemic regulation of cancer progression could guide development of new therapeutic modalities and efforts to prevent disease relapse following initial diagnosis and treatment.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25082194 PMCID: PMC6220424 DOI: 10.1038/ncb3015
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824